Europe Pharmaceutical Blister Packaging Market Size (2024 - 2029)

Europe Pharmaceutical Blister Packaging Market Analysis

The Europe Pharmaceutical Blister Packaging Market size is estimated at USD 4.76 billion in 2024, and is expected to reach USD 6.61 billion by 2029, growing at a CAGR of 6.77% during the forecast period (2024-2029).

Pharmaceutical blister packaging plays a substantial role in ensuring the safety of drugs and medicine against unfavorable external influences such as biological contamination, counterfeiting, etc. The market is expected to grow due to the demand for drug delivery in blister packaging.

• The rise in the consumption rate of generic drugs and the growth in the pharmaceutical sector in emerging economies are projected to influence the market's growth. Rapid technological advancements, a rise in health awareness, and the adoption of new regulatory standards drive the demand.
• According to Flexible Packaging Europe, the first aspirins were made from aluminum foil in strip packaging. This foil material is used exclusively for blister packaging. Also, rising awareness regarding the importance of high-quality pharmaceutical packaging material, especially during transport and storage, is expected to drive market growth.
• The pharmaceutical sector is one of the important industries for the United Kingdom, owing to the significant usage of drugs, improvement in medical science, and the increasing number of diseases in the country. The region's vital, well-established pharmaceutical sector comprises domestic companies and inward investors.
• The market is expected to grow as the pharmaceutical sector is one of the significant engines of innovation and research. The sector is spending billions of dollars on R&D and employing vast numbers for highly skilled R&D roles. These massive investments and the proportion of skilled workers show how the region is building the pipeline of medicines and future drugs. This is an ideal opportunity for the packaging vendors. 
• According to a study by Copenhagen Economics A/S in 2023, the EU pharmaceutical industry faced significant changes to the EU pharmaceutical legislation over the last two decades, impacting the incentives to develop and market orphan and non-orphan medicines. With the revision, the European Commission (EC) is offering measures to allow for faster access to generic medicines while at the same time incentivizing the continued development and introduction to the market of innovative medicines. Such changes would leverage the demand for blister packaging in the region.
• According to the Organization for Economic Co-operation and Development (OECD), the pharmaceutical sector's costs and pricing structure are often indistinct, and there are legitimate inquiries about the degree of innovation and value offered by increasingly costly new treatments. Aluminum and plastic were used in pharmaceutical blister packaging. Over time, these materials became too expensive (due to raw material prices and other factors) to provide a commercially viable solution for packaging high-volume products.

Europe Pharmaceutical Blister Packaging Industry Segmentation

Blister packs allow the customers to keep track of doses of medicine with marked details and allow ease of storage for future purposes. Additionally, storing and handling the blister pack is convenient for commercial and household purposes, as the chances of damage are minimal.

The European pharmaceutical blister packaging market is segmented by material (plastic, paper, and aluminum), technology (cold forming and thermoforming), and country (the United Kingdom, Germany, Italy, France, Spain, and the Rest of Europe). The report offers market sizes and forecasts in terms of value (USD) for all the above segments.